Garen G. Bohlin, Director at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 8,700 shares at $37.18 ($323K) on 2026-05-11, disclosed to the SEC on 2026-05-13.
Seasonal sale ($323k) by Director — this insider has traded COLL in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| KPTI | BUY | 2021-05-10 | $31K | — | Filing → |